Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular profiling for cancer identification, Beacon carrier screening for inherited conditions, and specialized rapid whole genome testing for critically ill infants in NICU and PICU units. Other offerings include a newborn genetic analysis panel, a front-line test to sequence ataxia-related variants, and patient-initiated genetic testing via Picture Genetics. They also provide comprehensive whole exome, clinical exome, whole genome, mutation, and repeat expansion testing, alongside research service tests. For COVID-19, the company delivers next-generation sequencing, reverse transcription polymerase chain reaction (RT-PCR), and antigen-based diagnostic solutions for SARS-CoV-2. Beyond genetic and COVID-19 diagnostics, Fulgent Genetics performs advanced laboratory analyses such as flow cytometry for cell analysis and malignancy monitoring, fluorescence in-situ hybridization (FISH) for specific DNA sequence detection, immunohistochemistry (IHC) to visualize cellular antigens, and cytogenetics for assessing chromosomal anomalies, in addition to molecular testing for both hematopoietic and solid tumors. Their clientele is broad, including insurance companies, hospitals, medical institutions, fellow laboratories, government agencies, payors, municipal bodies, major corporations, and direct patients. The company has formed a strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. Founded in 2011 and headquartered in Temple City, California, the company was previously known as Fulgent Diagnostics, Inc. before adopting its current name in August 2016.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
Fulgent Genetics, Inc.
NASDAQ:FLGTHealthcare · Medical - Diagnostics & Research
-4.89%$20.62
AH$20.62+0.00%vs close
Mkt Cap$567.37M
Float17.79M
O/S27.52M
Vol
$ Vol
RVOL
Inst Own56.7%
SI12.0%
Earnings
Dilution
Financials Summary
Revenue$322.67M
Net Income-$60.51M
Total Assets$1.21B
Free Cash Flow-$124.21M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$7.68M
Total Equity$1.11B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in FLGT's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.21B
Liabilities$106.81M
Accounts Receivable$91.61M
Accounts Payable$18.65M
Inventory$10.6M
PP&E (Net)$112.55M
Goodwill$25.08M
Intangible Assets$133.28M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $322.67M | $283.47M | $289.21M | $618.97M | $992.58M | $421.71M | $32.53M | $21.36M | $18.73M | $18.28M | $9.58M | $1.28M |
| YoY Growth | 13.8% | -2.0% | -53.3% | -37.6% | 135.4% | 1196.5% | 52.3% | 14.0% | 2.5% | 90.9% | 649.3% | - |
| Cost of Revenue | $191.8M | $176.25M | $184.76M | $252.07M | $215.53M | $89.81M | $14.11M | $10.69M | $8.55M | $6.72M | $5.07M | $936K |
| Gross Profit | $130.88M | $107.22M | $104.46M | $366.9M | $777.05M | $331.9M | $18.42M | $10.66M | $10.18M | $11.55M | $4.51M | $342K |
| Gross Margin | 40.6% | 37.8% | 36.1% | 59.3% | 78.3% | 78.7% | 56.6% | 49.9% | 54.3% | 63.2% | 47.1% | 26.8% |
| Research and Development | $53.91M | $48.82M | $41.44M | $28.91M | $24.22M | $11.58M | $6.54M | $5.53M | $4.22M | $3.56M | $4.43M | $521K |
| Selling, General, and Administrative | $160.03M | $124.35M | $130.47M | $149.99M | $75.17M | $30.17M | $12.31M | $10.19M | $9.44M | $7.08M | $5.09M | $811K |
| Other | $8.03M | $7.96M | $128.08M | $9.47M | $1.71M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $221.97M | $181.13M | $299.99M | $188.37M | $101.1M | $41.75M | $18.85M | $15.72M | $13.58M | $10.64M | $9.52M | $1.33M |
| Operating Income (EBIT) | -$91.1M | -$73.92M | -$195.53M | $178.53M | $675.95M | $290.16M | -$428K | -$5.07M | -$3.48M | $919K | -$5.01M | -$990K |
| Operating Margin | -28.2% | -26.1% | -67.6% | 28.8% | 68.1% | 68.8% | -1.3% | -23.7% | -18.6% | 5.0% | -52.3% | -77.5% |
| Interest Expense | $75K | $170K | $488K | $1.01M | $0 | $0 | $0 | $0 | $0 | $5.39M | $0 | $0 |
| Interest Income | $30.92M | $31.3M | $21.61M | $5.62M | $1.35M | $1.53M | $837K | $434K | $481K | $0 | $27K | $0 |
| Other Income (Expense) | $21.07M | $21.96M | $21.44M | $5.5M | $5.08M | -$3.32M | $60K | $434K | $481K | -$5.39M | $27K | $0 |
| Income Before Tax (EBT) | -$70.03M | -$51.96M | -$174.09M | $184.03M | $681.03M | $286.84M | -$368K | -$4.64M | -$3M | -$4.47M | -$4.99M | -$990K |
| Income Tax Expense | -$8.39M | -$8.14M | $1.15M | $42.1M | $174.79M | $72.53M | $43K | $36K | -$1.01M | $920K | $3.33M | $3.29M |
| Net Income | -$60.51M | -$42.71M | -$167.82M | $143.4M | $507.36M | $214.31M | -$411K | -$5.61M | -$2.51M | -$5.35M | -$8.31M | -$4.28M |
| Net Income Margin | -18.8% | -15.1% | -58.0% | 23.2% | 51.1% | 50.8% | -1.3% | -26.3% | -13.4% | -29.3% | -86.8% | -335.1% |
| Supplementary Data | ||||||||||||
| EPS | -1.97 | -1.41 | -5.63 | 4.76 | 17.13 | 9.44 | -0.02 | -0.25 | -0.15 | -0.30 | -0.64 | -0.34 |
| Diluted EPS | -1.97 | -1.41 | -5.63 | 4.63 | 16.26 | 8.91 | -0.02 | -0.25 | -0.15 | -0.30 | -0.64 | -0.34 |
| Weighted Average OS | 30.78M | 30.23M | 29.78M | 30.10M | 29.41M | 22.69M | 18.71M | 17.98M | 17.74M | 17.68M | 12.77M | 17.68M |
| EBITDA | -$45.83M | -$26.86M | -$147.45M | $217.7M | $692.04M | $293.12M | $1.68M | -$2.91M | -$1.75M | $2.09M | -$4.44M | -$794K |
| EBITDA Margin | -14.2% | -9.5% | -51.0% | 35.2% | 69.7% | 69.5% | 5.2% | -13.6% | -9.4% | 11.4% | -46.3% | -62.1% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $50.19M | $55.14M | $97.47M | $79.51M | $164.89M | $87.43M | $11.96M | $6.74M | $6.49M | $7.9M | $489K | $172K |
| Short-Term Investments | $285.88M | $202.96M | $326.68M | $446.73M | $285.61M | $211.94M | $16.3M | $30.68M | $34.88M | $38.57M | $0 | $0 |
| Cash and Short-Term Investments | $336.08M | $258.11M | $424.15M | $526.24M | $450.5M | $299.37M | $28.27M | $37.42M | $41.37M | $46.47M | $489K | $172K |
| Accounts Receivable | $91.61M | $77.03M | $57.45M | $75.11M | $143.29M | $204.06M | $7.2M | $6.24M | $4.07M | $4.36M | $2.15M | $387K |
| Inventory | $10.6M | $8.38M | $5.83M | $4.28M | $12.21M | $16.49M | $277K | $314K | $231K | $322K | $212K | $141K |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $231K | $322K | $221K | $0 |
| Total Current Assets | $550.49M | $353.57M | $507.85M | $627.87M | $611.96M | $523.62M | $37.08M | $43.37M | $45.37M | $50.83M | $2.93M | $710K |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $112.55M | $105.55M | $83.46M | $81.35M | $62.29M | $40.2M | $8.61M | $6.45M | $7.27M | $6.23M | $2.47M | $978K |
| Goodwill | $25.08M | $22.05M | $22.05M | $143.03M | $50.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $133.28M | $134.98M | $143.05M | $150.64M | $35.91M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $369.27M | $570.35M | $444.01M | $339.03M | $507.01M | $132.5M | $42.82M | $7.9M | $16.82M | $25.6M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $718K | $126K | $54K | $0 | $0 |
| Other Long-Term Assets | $22.86M | $33.46M | $34.9M | $44.12M | $10.65M | $4.14M | $251K | -$2.7M | $4.31M | $977K | $433K | $432K |
| Total Long-Term Assets | $663.03M | $866.39M | $727.48M | $758.18M | $666.76M | $176.84M | $51.68M | $11.64M | $11.58M | $7.21M | $2.9M | $1.41M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.21B | $1.22B | $1.24B | $1.39B | $1.28B | $700.46M | $88.76M | $55.02M | $56.95M | $58.04M | $5.83M | $2.12M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $18.65M | $18.36M | $15.36M | $23.09M | $20.49M | $26.49M | $1.58M | $1.31M | $2.09M | $2.76M | $314K | $165K |
| Short-Term Debt | $476K | $412K | $1.18M | $20.64M | $21.28M | $15.02M | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $107.1M | $0 | $0 | $0 | $787K | $53.32M | $24K | $0 | $0 | $124K | $0 | $0 |
| Current Unearned Revenue | $31.78M | $29.84M | $25.57M | $14.09M | $34.38M | $26.76M | $365K | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $10.46M | $9.89M | $6.42M | $5.3M | $10.68M | -$185K | $0 | $166K | $0 | $0 | $173K | $134K |
| Total Current Liabilities | $84.97M | $72.9M | $73.02M | $88.11M | $105.31M | $130.12M | $3.72M | $2.75M | $2.92M | $3.56M | $686K | $436K |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $1.96M | $2.49M | $2.96M | $3.37M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $6.94M | $6.37M | $7.96M | $0 | $0 | $0 | $0 | $718K | $820K | $243K | $0 | $0 |
| Other Long-Term Liabilities | $9.17M | $4.92M | $10.95M | $15.9M | $7.53M | $391K | $0 | $14K | $6K | $2K | $0 | $0 |
| Total Long-Term Liabilities | $21.84M | $17.91M | $29.02M | $28.07M | $7.53M | $959K | $2.26M | $14K | $6K | $245K | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$14K | -$6K | -$245K | $0 | $0 |
| Total Liabilities | $106.81M | $90.81M | $102.04M | $116.18M | $112.84M | $131.07M | $5.98M | $2.75M | $2.92M | $3.56M | $686K | $436K |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.12M | $0 | $0 | $45.99M | $12M |
| Common Stock | $3K | $3K | $3K | $3K | $3K | $3K | $2K | $2K | $2K | $2K | $12.32M | $0 |
| Retained Earnings | $529.95M | $590.47M | $633.17M | $801M | $657.6M | $150.88M | -$63.43M | -$63.02M | -$57.66M | -$55.15M | -$53.16M | -$10.32M |
| Comprehensive Income & Other | $7.51M | -$368K | $1.21M | -$20.9M | -$759K | $438K | $146K | -$35K | -$44K | -$103K | -$900K | -$372K |
| Other Stockholders' Equity | $582.03M | $542.76M | $502.92M | $465.68M | $501.15M | $418.5M | $146.2M | $115.29M | $111.69M | $109.63M | $45.99M | $12M |
| Total Equity | $1.11B | $1.13B | $1.14B | $1.27B | $1.16B | $569.39M | $82.78M | $52.27M | $54.03M | $54.48M | $5.15M | $1.68M |
| Minority Interest | -$5.27M | -$4.07M | -$2.81M | $3.19M | $7.13M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.22B | $1.22B | $1.24B | $1.38B | $1.27B | $700.46M | $88.76M | $55.02M | $56.95M | $58.04M | $5.83M | $2.12M |
| Supplementary Data | ||||||||||||
| Total Debt | $7.68M | $8.47M | $15.25M | $38.94M | $21.28M | $15.85M | $2.68M | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$42.52M | -$46.68M | -$82.22M | -$40.57M | -$143.61M | -$71.57M | -$9.29M | -$6.74M | -$6.49M | -$7.9M | -$489K | -$172K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$61.63M | -$43.82M | -$175.24M | $141.92M | $506.24M | $214.31M | -$411K | -$5.61M | -$2.51M | -$5.39M | -$4.99M | -$990K |
| Depreciation & Amortization | $24.12M | $24.93M | $26.14M | $32.66M | $11M | $2.96M | $2.11M | $2.16M | $1.73M | $1.17M | $575K | $196K |
| Deferred Income Tax | -$1.21M | -$5.15M | $7.61M | $831K | -$7.84M | -$1.4M | -$21K | $36K | -$336K | $246K | -$3.33M | $0 |
| Stock-Based Compensation | $39.58M | $44.48M | $42.92M | $32.64M | $15.88M | $8.16M | $0 | $2.3M | $2.12M | $4.65M | $8.16M | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$23.25M | -$16.3M | $2.39M | $68.64M | $42.3M | -$178.48M | -$839K | -$1.97M | $214K | -$2.32M | -$1.78M | -$416K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$36.18M | -$30.49M | -$23.45M | -$2.35M | -$331K |
| Accounts Payable | $550K | $3.07M | -$6.9M | -$25.34M | -$12.21M | $22.62M | -$329K | $102K | -$363K | $1.09M | $132K | $150K |
| Other Working Capital | -$94.93M | $6M | $7.35M | -$41.29M | -$32.77M | $64.41M | $253K | $36.8M | $29.93M | $22.82M | $2.24M | $274K |
| Total Working Capital Change | -$117.63M | -$7.24M | $2.84M | $2M | -$2.68M | -$91.45M | -$915K | -$1.24M | -$714K | -$1.86M | -$1.75M | -$323K |
| Other Non-Cash Items | $15.14M | $7.86M | $122.73M | $43.46M | $15.97M | $8.05M | $4.76M | $1.67M | $1.04M | $5.58M | $362K | -$3.28M |
| Net Cash from Operating | -$101.64M | $21.06M | $27M | $253.52M | $538.58M | $140.63M | $5.52M | -$675K | $1.33M | $4.41M | -$969K | -$4.4M |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$22.57M | -$40.31M | -$22.21M | -$18.77M | -$23.81M | -$36.51M | -$1.18M | -$2.83M | -$5.36M | -$3.79M | -$2.1M | -$731K |
| Acquisitions | $3.77M | $0 | -$399K | -$182.68M | -$61.87M | -$2.59M | $0 | $510K | $2.46M | $10K | $3.57M | $0 |
| Purchases of Investments | -$80.84M | -$472.42M | -$491.91M | -$432.98M | -$730.49M | -$324.36M | -$52.21M | -$24.19M | -$11.66M | -$39.02M | $0 | $0 |
| Sales of Investments | $211.01M | $454.06M | $552.64M | $372.71M | $269.59M | $37.01M | $24.35M | $27.97M | $14.97M | $0 | $0 | $0 |
| Other Investing Activities | $5K | $313K | $775K | $412K | $31K | $8K | $0 | -$510K | -$2.46M | $10K | -$105K | -$49K |
| Net Cash from Investing | $111.37M | -$58.35M | $38.9M | -$261.31M | -$546.55M | -$326.44M | -$29.05M | $950K | -$2.05M | -$42.8M | -$2.21M | -$780K |
| Financing Activities | ||||||||||||
| Debt Repaid | $399K | $544K | $730K | $700K | $7K | - | - | - | - | - | - | - |
| Common Stock Issuance | $1K | $0 | $0 | $0 | $89.47M | $246.19M | $28.8M | $15K | -$770K | $36.79M | $0 | $0 |
| Common Stock Repurchases | -$13.92M | -$3.12M | -$27.79M | -$76.11M | -$4.16M | -$62K | -$21K | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$159K | $0 | $0 |
| Other Financing Activities | $0 | $51K | $3K | $31K | $96K | $104K | $0 | $15K | -$770K | -$1.41M | $3.5M | $4M |
| Net Cash from Financing | -$14.79M | -$4.85M | -$47.78M | -$77.14M | $85.41M | $261.25M | $28.77M | $15K | -$770K | $45.79M | $3.5M | $4M |
| Forex Effect | $105K | -$55K | -$149K | -$453K | $34K | $20K | -$17K | -$44K | $81K | $0 | $0 | $0 |
| Net Change in Cash | -$4.95M | -$42.19M | $17.97M | -$85.39M | $77.47M | $75.46M | $5.23M | $246K | -$1.41M | $7.4M | $326K | -$1.18M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$101.64M | $21.06M | $27M | $253.52M | $538.58M | $140.63M | $5.52M | -$675K | $1.33M | $4.41M | -$969K | -$4.4M |
| Capital Expenditure | -$22.57M | -$40.31M | -$22.21M | -$18.77M | -$23.84M | -$36.51M | -$1.18M | -$2.83M | -$5.36M | -$3.79M | -$2.1M | -$731K |
| Free Cash Flow | -$124.21M | -$19.25M | $4.8M | $234.75M | $514.73M | $104.12M | $4.33M | -$3.51M | -$4.03M | $617K | -$3.07M | -$5.13M |
| Cash at Beginning | $55.28M | $97.47M | $79.51M | $164.89M | $87.43M | $11.96M | $6.74M | $6.49M | $7.9M | $498K | $172K | $1.35M |
| Cash at End | $50.33M | $55.28M | $97.47M | $79.51M | $164.89M | $87.43M | $11.96M | $6.74M | $6.49M | $7.9M | $498K | $172K |